You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intravenous Infusion

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction, CLDN18.2-positive Adenocarcinoma of Esophagus,

Completed
  • CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
  • +2 more
  • Plovdiv, Bulgaria
  • +47 more
Jan 14, 2020

Knee Arthroplasty Trial in Kingston (Magnesium Sulfate, Ropivacaine, Sham)

Completed
  • Knee Arthroplasty
  • Magnesium Sulfate
  • +2 more
  • Kingston, Ontario, Canada
  • +1 more
Nov 10, 2020

Laceration Repair Trial in London (Dexmedetomidine)

Completed
  • Laceration Repair
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 5, 2022

Disease and Risk of Future Cardiovascular Events in Survivors

Recruiting
  • Preeclampsia
  • Eclampsia
    • Sagamu, Ogun, Nigeria
      Babcock University Teaching Hospital
    Jul 8, 2020

    Bariatric Surgery Candidate, Glucose Intolerance, Insulin Resistance Trial (Dexmedetomidine, 0.9% Sodium-chloride, Fentanyl)

    Completed
    Has Results
    • Bariatric Surgery Candidate
    • +2 more
    • (no location specified)
    Sep 9, 2020

    Hepatocellular Carcinoma Trial (Pembrolizumab)

    Active, not recruiting
    Has Results
    • Hepatocellular Carcinoma
    • Pembrolizumab
    • (no location specified)
    Dec 15, 2022

    Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)

    Completed
    Has Results
    • Urothelial Carcinoma
    • Bladder Cancer
    • Phoenix, Arizona
    • +27 more
    Sep 16, 2022

    Cancer, Bladder, Surgery, Anesthesia Trial in Cairo (Erector Spinae Plane Block, Thoracic Paravertebral Plane Block, Quadratus

    Recruiting
    • Cancer, Bladder
    • +4 more
    • Erector Spinae Plane Block
    • +2 more
    • Cairo, Egypt
      Cairo University Hospitals
    Mar 26, 2022

    Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

    Recruiting
    • Hematological Malignancy
    • Cancer-Related Anemia
    • Shengxuening Tablet
    • Ferrous succinate
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Mar 13, 2023

    Carcinoma, Non-Squamous Non-Small Cell Lung Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody,

    Completed
    Has Results
    • Carcinoma, Non-Squamous Non-Small Cell Lung
    • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
    • +3 more
    • Springdale, Arkansas
    • +131 more
    Jul 15, 2021

    Stress Fracture Foot, Stress Fracture Ankle Trial in Oslo (Zoledronic Acid Injectable Product, Placebo)

    Terminated
    • Stress Fracture Foot
    • Stress Fracture Ankle
    • Zoledronic Acid Injectable Product
    • Placebo
    • Oslo, Norway
      Oslo University Hospital
    Sep 11, 2019

    Renal Cell Carcinoma Trial in Washington, Indianapolis (Entinostat, Nivolumab, Ipilimumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Washington, District of Columbia
    • +1 more
    Jan 10, 2022

    Living Donor Liver Transplantation Trial in Pittsburgh (Regulatory Donor-Derived Dendritic Cell infusion)

    Active, not recruiting
    • Living Donor Liver Transplantation
    • Regulatory Donor-Derived Dendritic Cell infusion
    • Pittsburgh, Pennsylvania
      UPMC
    Sep 2, 2021

    SARS CoV-2 Virus Secretions and Serum for Countermeasure

    Recruiting
    • Covid19
      • New Orleans, Louisiana
      • +1 more
      Jul 19, 2022

      Natural History Study of CADASIL

      Recruiting
      • Cardiovascular Disease
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Oct 29, 2022

        Bronchiolitis Trial in Sacramento (Bronchiolitis quality improvement)

        Completed
        • Bronchiolitis
        • Bronchiolitis quality improvement
        • Sacramento, California
          UC David Medical Center
        May 12, 2022

        Burn Body Region Unspecified, Burn Shock Trial (Oral Rehydration Solution, Lactated Ringer)

        Not yet recruiting
        • Burn Body Region Unspecified
        • Burn Shock
        • Oral Rehydration Solution
        • Lactated Ringer
        • (no location specified)
        Sep 25, 2022

        Intraoperative Pain Control Trial (dexmedetomidine 5 mcg mixed with 0.5% plain bupivacaine)

        Not yet recruiting
        • Intraoperative Pain Control
        • dexmedetomidine 5 mcg mixed with 0.5% plain bupivacaine
        • (no location specified)
        Mar 3, 2021

        COVID-19, SARS-CoV 2, Coronavirus Infection Trial in Madrid (Melatonin intravenous, Placebo intravenous)

        Completed
        • COVID-19
        • +2 more
        • Melatonin intravenous
        • Placebo intravenous
        • Madrid, Spain
          Hospital Universitario La Paz
        Mar 17, 2021

        Carcinoma, Hepatocellular, Liver Tumors, Sintilimab Trial in Guangzhou (Hepatic arterial infusion chemo, Lenvatinib, Sintilimab)

        Unknown status
        • Carcinoma, Hepatocellular
        • +3 more
        • Hepatic arterial infusion chemotherapy
        • +2 more
        • Guangzhou, Guangdong, China
          Second Affiliated Hospital of Guangzhou Medical University
        Dec 20, 2020

        Frail Elderly Syndrome, Aging, Degenerative Disease Trial in Colchester (procedure, device, drug)

        Enrolling by invitation
        • Frail Elderly Syndrome
        • +2 more
        • Microcannula harvest adipose stromal tissues
        • +4 more
        • Colchester, Vermont
          Fanny Island Campus Medical Building
        Mar 25, 2020

        Acute Decompensated Heart Failure, Diuretics Resistance Trial in Cairo (Frusemide IV shots, Frusemide IV infusion)

        Recruiting
        • Acute Decompensated Heart Failure
        • Diuretics Resistance
        • Frusemide IV shots
        • Frusemide IV infusion
        • Cairo, Egypt
          Faculty of Medicine, Cairo University Hospitals
        Jan 26, 2021

        Treatment of Acute Zika Virus Infection Trial in Singapore (Tyzivumab, Placebo)

        Withdrawn
        • Treatment of Acute Zika Virus Infection
        • Tyzivumab
        • Placebo
        • Singapore, Singapore
          SingHealth Investigational Medicine Unit
        Mar 8, 2022

        HER2-positive Breast Cancer Trial in Guangzhou, Hangzhou (Pertuzumab, Trastuzumab, Fulvestrant)

        Not yet recruiting
        • HER2-positive Breast Cancer
        • Guangzhou, Guangdong, China
        • +1 more
        Apr 5, 2020

        Spasm Trial in Busan (Spasm positive, Spasm negative)

        Unknown status
        • Spasm
        • Spasm positive
        • Spasm negative
        • Busan, Korea, Republic of
          Dong-A University Hospital
        Aug 3, 2020